Long-acting insulin analogues in type 1 diabetes: No proof of additional benefit
Wednesday, May 12, 2010 - 10:11
in Health & Medicine
It has so far not been proven that the long-acting insulin analogues (LAIAs) insulin detemir (trade name: Levemir) and insulin glargine (trade name: Lantus), which are approved for the treatment of...